Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 2

In the second installment of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss clinical guidance for managing patients who may experience neurotoxicity from CAR T-cell, with a specific focus on seizure risk. 

Show reference: 

https://www.neurology.org/doi/10.1212/WNL.0000000000213535